Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Aurobindo Pharma Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for AUROBINDO PHARMA, and what generic and branded alternatives to AUROBINDO PHARMA drugs are available?

AUROBINDO PHARMA has three hundred and sixty approved drugs.

There are nineteen tentative approvals on AUROBINDO PHARMA drugs.

Drugs and US Patents for Aurobindo Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd AUROVELA 1.5/30 ethinyl estradiol; norethindrone acetate TABLET;ORAL-21 207581-001 Jun 26, 2017 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma PENICILLIN V POTASSIUM penicillin v potassium TABLET;ORAL 065435-001 Apr 29, 2008 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd DIVALPROEX SODIUM divalproex sodium TABLET, DELAYED RELEASE;ORAL 090554-003 Apr 21, 2011 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd OLANZAPINE olanzapine TABLET, ORALLY DISINTEGRATING;ORAL 203708-002 May 15, 2014 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma METOPROLOL TARTRATE metoprolol tartrate TABLET;ORAL 077739-001 Sep 11, 2007 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd ICLEVIA ethinyl estradiol; levonorgestrel TABLET;ORAL 206850-001 Jun 29, 2018 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER levofloxacin INJECTABLE;INJECTION 206919-003 Feb 10, 2016 AP RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for AUROBINDO PHARMA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.